Fuentes, Jonathan B.
HRN: 24-31-73 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2024
MUPIROCIN 2%, 15G (TUBE)
01/06/2024
01/12/2024
TOPICAL
2%
BID
Open Lesions Both Feet
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes